How it works.

PainChek® uses AI, facial recognition and smartphone technology to intelligently automate the pain assessment process at the point of care.


Available for download from the App Store or Google Play.

Complete digital pain assessments in under 3 minutes.

Seamless online onboarding, training and implementation.

Who it's for.

PainChek® is a clinically proven medical device to improve pain assessments and pain management for people living with dementia or other cognitive impairment. The digital tool is currently available in the care home market, with expansion plans to extend into the home care market soon.*

PainChek® is designed to be used by nurses and carers whilst providing care to residents throughout the day or during key interventions which may trigger pain. The user-friendly assessment process can be completed in around 2 minutes, this results in the ability of more frequent pain assessments as it requires far less investment of time in comparison to paper-based assessments. Also, due to it being app-based, care teams can benefit from the assistance of a medical device straight from their pocket.

*If you are a home care provider and interested in PainChek®, do still reach out and we will be happy to discuss your requirements.


Case Studies.

PainChek® is currently used in over 900 aged care facilities globally – giving over 50,000 people access to better pain assessment and management. Below are three studies that explain the impact PainChek. Other case studies may be accessed here.

Improving the quality of life for residents at Barossa Village.


Supporting evidence-based care and streamlining operations for Allambie Heights.


Empowering nurses and carers at Heathfield Residential Village.


Resource Centre.

The latest research, studies, and announcements from the PainChek® team.

image of desk and hands using an iPad

Latest News.


Case Studies.


Brochures & Clinical Studies.


Sign up to receive our latest news and information.

Join for exclusive access to white papers, industry news, clinical studies, and more.

Want a preview? Read our latest newletter here.

Follow Us on Social Media